BDSX today
$9.88+$0.09 (+0.92%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourBearish
15 minSymmetric Triangle
5 minStrong Bearish
Daily trend turns up above $31.97
Key levels
Resistance$14.79
Resistance$12.13
Support$7.70
Support$5.26
Latest news & SEC filings
NewsBiodesix Insider Purchases Shares
SEC FilingBiodesix Inc filed an insider trading report (Form 4)
AnalystHC Wainwright keeps Buy rating on Biodesix, cuts price target to $34
All BDSX news →About Biodesix
Biodesix is a diagnostics company focused on lung disease. It offers blood-based tests that help assess lung nodule cancer risk and guide treatment for lung cancer patients, sold to healthcare providers such as pulmonologists and primary care networks. It also provides diagnostic testing and consulting services to biopharmaceutical and life sciences companies. The company operates in the United States.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
BIODESIX INC (BDSX)
What Is the Price Target for BDSX?
SEPT Low Target
$27.00
SEPT Mid Target
$32.00
SEPT High Target
$40.00
Analyst Consensus
$32.00
Is BDSX a Buy or Sell Right Now?
Thesis
- •Revenue growing 24.1% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BDSX.
Start Free Trial →Is BDSX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$24.58
13
Moat Score
NONE
3/9
Piotroski Score
-6.7
Altman Z-Score
What Is Smart Money Doing with BDSX?
Insider Signal
SELLING
3 buys / 15 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| SCHULER JACK W | 10% owner | Buy | 100,000 | $1.0M | Nov 10, 2026 |
| PATIENCE JOHN | director | Buy | 1,360 | - | Sep 30, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BDSX Growth Story
Revenue YoY
24.1%
3yr Revenue CAGR
32.3%
EPS Growth YoY
29.67%
FCF Growth YoY
54.6%
Revenue Trend
STRONG
Dark Pool Trades for BDSX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BDSX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:22 | $9.88 | 1,196 | $$12K | SELL |
| 21:00:21 | $9.88 | 1,544 | $$15K | SELL |
| 20:56:58 | $9.98 | 1,000 | $$10K | MIDPOINT |
| 20:52:45 | $10.10 | 1,700 | $$17K | SELL |
| 20:16:11 | $10.31 | 1,819 | $$19K | SELL |
5 dark pool trades shown · $$73K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BIODESIX INC (BDSX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BDSX — frequently asked questions
What is BDSX stock price today?
BIODESIX INC (BDSX) is at $9.88, up 0.92% (+$0.09) at the Nov 13, 2026 close.
Why is BDSX stock moving today?
Latest BDSX news — Nov 13, 2026: Biodesix Insider Purchases Shares · Nov 12, 2026: Biodesix Inc filed an insider trading report (Form 4)
What is the BDSX price target?
The average analyst price target for BDSX is $32.00, ranging from $27 to $40, based on 5 analysts. Latest: TD Cowen maintains on Oct 13, 2026.
What do analysts rate BDSX?
Analyst ratings for BDSX: 2 Buy, 7 Hold, 0 Sell — consensus Hold.
Did BDSX beat earnings?
BDSX last reported on Nov 5, 2026: EPS -$0.75 vs -$0.75 expected — a miss of 0.2%.
Does BDSX pay a dividend?
BDSX does not currently pay a dividend.
How much debt does BDSX have?
BIODESIX INC reported $50M of debt and $30M of cash (Jun 30, 2026).
What are BDSX support and resistance levels?
Support: $7.70, $5.26. Resistance: $12.13, $14.79, $17.21.
What are insiders doing with BDSX?
Insider activity: SELLING, 3 buys and 15 sells in the last 90 days.
What is the latest news on BDSX?
Nov 13, 2026: Biodesix Insider Purchases Shares · Nov 12, 2026: Biodesix Inc filed an insider trading report (Form 4) · Nov 9, 2026: HC Wainwright keeps Buy rating on Biodesix, cuts price target to $34